AshishManneMD

Gastrointestinal Cancer

Assistant Professor, Internal Medicine, Ohio State University. The James Comprehensive Cancer Center.

Dr. Manne is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
460 W 10th Ave
Columbus, OH 43210
Phone+1 614-293-5066

Fax+1 614-293-9449

Dr. Ashish Manne is an oncologist based in Columbus, OH, specializing in gastrointestinal cancer. He completed his medical education at Osmania Medical College and pursued further training with a residency in internal medicine and fellowships in blood banking/transfusion medicine and medical oncology. Dr. Manne currently serves as an Assistant Professor at The OSUCCC - James. His publication history includes research on pancreatic cancer, advanced gastrointestinal cancers, and immune checkpoint inhibitors, contributing to journals like the Journal of the American College of Surgeons, Gastroenterology Research, and Frontiers in Medicine.

USA HealthFellowship, Medical Oncology, 2018 - 2020
University of Alabama Medical CenterFellowship, Blood Banking/Transfusion Medicine, 2017 - 2018
University of Alabama Medical Center (Montgomery)Residency, Internal Medicine, 2014 - 2017
Osmania Medical College NTR UHSClass of 2011

PubMed

Textbook Neoadjuvant Experience: Defining a Novel Composite Outcomes Measure for Patients with Pancreatic Cancer Undergoing Neoadjuvant Therapy.
Patrick W Underwood, Thomas Leuschner, Aslam Ejaz, Mary Dillhoff, Susan Tsai
Journal of the American College of Surgeons. 2025-04-01
Riluzole in Combination with mFOLFOX6 and Bevacizumab in Treating Patients with Metastatic Colorectal Cancer: A Phase 1 Clinical Trial.
Chunjie Li, Anne M Noonan, John Hays, Sameek Roychowdhury, Pannaga Malalur
Clinical Cancer Research. 2025-03-21
Neoadjuvant immune checkpoint inhibitors for hepatocellular carcinoma.
Vinita Akula, Lily Chen, Yusuf Acikgoz, Katherine Klein, Betul Gok Yavuz
NPJ Precision Oncology. 2025-03-06

Lectures

The adherence to The American Association for The Study of Liver Disease (AASLD) guidelines in treating patients with hepatocellular carcinoma: Institutional experience.
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
Hepatic and hematological toxicity associated with selective internal radiation therapy (SIRT): A meta-analysis of randomized clinical trials.
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020